CLINICAL_TRIALS ClinicalTrials.gov record update

A Randomized Placebo-Controlled, 12-Week Multicenter Study of the Safety and Efficacy of Continuous or Daily Administration of Remodulin® (Treprostinil Sodium) Injection in Patients With CLI With No Planned Revascularization Procedures

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT00060996
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:35:21.418276+00:00
Published At: 2013-03-07T00:00:00+00:00
Record Updated At: 2013-03-07
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Critical Limb Ischemia", "Peripheral Vascular Disease", "Foot Ulcers", "Rest Leg Pain"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2013-03-07"
protocolSection.identificationModule.nctId: "NCT00060996"
protocolSection.identificationModule.officialTitle: "A Randomized Placebo-Controlled, 12-Week Multicenter Study of the Safety and Efficacy of Continuous or Daily Administration of Remodulin\u00ae (Treprostinil Sodium) Injection in Patients With CLI With No Planned Revascularization Procedures"
protocolSection.statusModule.overallStatus: "TERMINATED"
protocolSection.designModule.phases: ["PHASE3"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.